Ctxr catalyst timeline
WebCurrent Catalyst Status as of April 4th : r/CTXR by TwongStocks Current Catalyst Status as of April 4th Last couple of weeks saw a couple of decent PRs from the company. … WebNext Catalyst: First PR from Ameriguard and first Financials. It is stupid to ignore this opportunity leaving room for 20x gains and minimal risk to lose money here in the long term due the crazy undervaluation.Screenshot support thesis
Ctxr catalyst timeline
Did you know?
WebIRC reported ORR was 36.2%. Lower limit of the CI was 25%. Upper limit was 48.7% . They barely met their threshold for efficacy. Which was defined as the lower limit of the CI exceeding 25.0%. WebDec 6, 2024 · The shares of CTXR have already shown they react well to new milestone/catalyst events (hitting $4.56/share in June of this year. Given the timeline for Mino-Lok and I/ONTAK detailed above, we see plenty of potential catalysts in the near term.
WebApr 6, 2024 · BioXcel Therapeutics, Inc. (NASDAQ: BTAI) announced that the FDA approved IGALMI (dexmedetomidine) sublingual film for the acute treatment of agitation … WebOct 16, 2024 · Citius Pharmaceuticals (Ticker: $CTXR) is only a couple months away from anticipated positive Phase 3 results for its lead …
WebBeen in 5 months. Sold half at peak and bought back in sub-3. Seems like I was a bit early. I'll be in for months or years to come. Always the plan. Catalyst was just an opportunity to improve my position. I'm about 10% … WebJul 22, 2016 · Specialty pharmaceutical company dedicated to the development & commercialization of therapeutic products for large & growing markets. $CTXR
WebNov 8, 2024 · CTXR has come a long way from its start fifteen years ago and a handful of catalysts have timed to give some possible large swings in share price over the coming 60+/- days. The long term outlook...
WebView the basic CTXR option chain and compare options of Citius Pharmaceuticals, Inc. on Yahoo Finance. how do you take clips from youtubeWebCitius Pharmaceuticals, Inc. (NASDAQ: CTXR) is a late-stage biopharmaceutical company with a focus on oncology, anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapies. Current price $1.51/share (at market close 12-3-21) phonetic meanWebAug 15, 2024 · $CTXR let me remind you that catalyst is in dec..smart investors jump in BEFORE the catalyst. If people cant hold for a month or two than go play lotto or … how do you take constructive criticismWebAccording to . 1 Wall Street analyst that have issued a 1 year CTXR price target, the average CTXR price target is $6.00, with the highest CTXR stock price forecast at $6.00 and the lowest CTXR stock price forecast at $6.00.The Wall Street analyst predicted. that Citius Pharmaceuticals's share price could reach $6.00 by Apr 3, 2024. phonetic medical dictionaryWebHello my fellow CTXR friends,. CTXR current price: $2.08. CTXR has been standing steady around the $1.90 - 2.10 range for about 3-4 weeks now.. We are finally closing into the day we have all been waiting for and that is the FDA approval of the Mino-lok. Today and tomorrow CTXR is holding a conference call on the Mino-lok phase 3 of the FDA … phonetic marathi typing in windows 10WebCitius Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CTXR updated stock price target summary. how do you take contraveWebApr 17, 2024 · As of 07/02/2024 our model portfolio has generated an overall return of 73.84% substantially above the 52.37% gain from the Russell 2000 over the same time frame. • • • Specializing in profiling... phonetic medical term